InvestorsHub Logo
Followers 2
Posts 188
Boards Moderated 0
Alias Born 01/09/2019

Re: dcaf7 post# 395

Wednesday, 06/07/2023 9:15:50 AM

Wednesday, June 07, 2023 9:15:50 AM

Post# of 572
They knew about the limited bioavailability from the beginning. They had strong pre-clinical data. They did not have G-3 available. They had reasonable expectations that they could find an effective G-1 oral dose. Got very close. My peeve is that they did not go with combinations at the beginning. Is what it is.

We are in different situation now.

COMBINATIONS
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent APTO News